Please assess the completion status of the following clinical trial:

Trial Title: Bypass vs. Ecmo in Lung Transplantation (BELT)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. The study population will be all patients requiring cardiopulmonary support while undergoing lung transplantation at our institution.~Exclusion Criteria:~1. Patients undergoing concomitant cardiac operations with indication for obligate use of cardiopulmonary bypass~2. Patient with specific anatomy that require full cardiac decompression such as severe pulmonary hypertension or large heart that are shifted severely into the left chest~3. Patients with high likelihood of significant pleural bleeding that will require returning the blood back into the cardiotomy reservoir~4. Patients bridged to transplant with ECMO~5. Cystic fibrosis/bronchiectasis/resistant infection patients where surgeon will need to remove both lungs prior to implantation~6. Patients who the surgeon feels would be better served with CPB rather than ECMO- These patients will be entered into a registry and followed.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cardiopulmonary Bypass (Type: None): There will be 40 patients placed on cardiopulmonary bypass during lung transplantation.
- Extracorporeal Membrane Oxygenation (Type: None): There will be 40 patients placed on ECMO during lung transplantation.

Based on this trial design, predict the completion outcome and termination type (if applicable).